BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Biotech Bay

  AcelRx Pharmaceuticals Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares

  July 24, 2013

   · 

  3 min read
• Drug Development

  Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease With Advanced Fibrosis

  July 24, 2013

   · 

  6 min read
• FDA

  FDA Issues 510(k) Clearance for Topcon’s Pascal Synthesis Laser

  July 24, 2013

   · 

  1 min read
• Business

  Genmab A/S Release: Arzerra® Second Quarter 2013 Net Sales Figures

  July 24, 2013

   · 

  1 min read
• ECETOC’s Work Recognised by Regulators

  July 24, 2013

   · 

  1 min read
• Business

  CellScape Corporation Names Ted Snelgrove as CEO

  July 24, 2013

   · 

  3 min read
• Pharm Country

  Creative Biolabs Expanses Custom Immunoassay Kits for Quantitative Detection

  July 24, 2013

   · 

  1 min read
• EKF diagnostic GmbH Launches ß-Hydroxybutyrate Strip Test at American Association for Clinical Chemistry 2013

  July 24, 2013

   · 

  4 min read
• Deals

  OncoMed Pharmaceuticals, Inc. Announces Closing of Initial Public Offering

  July 24, 2013

   · 

  1 min read
• Business

  Drug Innovation Ventures at Emory, LLC (DRIVE) Appoints Chief Executive Officer

  July 24, 2013

   · 

  3 min read